–
Aldeyra Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−56.2
FY22:
−62.7
FY23:
−42.8
FY24:
−60.1
FY25:
−35.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−55.8
FY22:
−60.1
FY23:
−35.2
FY24:
−53.7
FY25:
−31.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.8
FY22:
−62.0
FY23:
−37.5
FY24:
−55.9
FY25:
−33.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−57.8
FY22:
−62.0
FY23:
−37.5
FY24:
−55.9
FY25:
−33.8
All amounts in millions USD